Sweet GRAS for “Bitter blocker”
This article was originally published in The Tan Sheet
Executive Summary
FDA affirms adenosine monophosphate (AMP) - a natural compound that can be used to block the bitter taste of oral pharmaceuticals - as generally recognized as safe, Linguagen announces Sept. 15. AMP can "improve the taste" of products "without adding excess salt or sugar" and can be used in foods and beverages, Linguagen notes. The Cranbury, N.J.-based firm received a two-year, $746,000 NIH grant in 2002 to conduct research on AMP's ability to block the bitter taste signal pathway caused by pharmaceutical agents (1"The Tan Sheet" Oct. 7, 2002, p. 12)...
You may also be interested in...
OTC Drug Bitter Taste-Blocking Compound Receives $746,000 NIH Grant
NIH-funded research evaluating the efficacy of a bitter taste-inhibiting compound could result in the development of "more palatable" oral OTC drugs and subsequent improvements in patient compliance, according to grantee Linguagen Corp
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.